MDx BioAnalytical Laboratory, Inc. is a biotechnology startup that specializes in biomolecular characterization. Their slogan, "Defining Biomolecular Characterization", encapsulates their dedication to providing high-quality analytical research and services to pharmaceutical companies. They focus on the analysis of small and large molecular weight drugs and biomarker discovery, catering to the biotechnology, healthcare, and pharmaceutical industries.
The startup is positioned as a full-service analytical laboratory, offering GLP and cGMP analyses of pre-clinical and clinical compounds, including PK/PD studies. Though specifics regarding the year of establishment, headquarters, and recent investments are not provided, MDx BioAnalytical Laboratory, Inc. presents an opportunity for venture capitalists looking to invest in the biotechnology and pharmaceutical sectors. It's essential to further explore the company's growth trajectory and potential for market impact to assess its viability for investment. The absence of disclosed investment and investors, along with limited information on the founding date and headquarters, could indicate the need for further due diligence and evaluation prior to potential investment consideration.
There is no investment information
No recent news or press coverage available for MDx BioAnalytical Laboratory, Inc..